Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02367599 · ClinicalTrials.gov registry record · Phase 4
Effect of Vitamin D Supplementation on Bone Turnover Markers During PrEP in MSM
A Phase 4 study, sponsored by University of California, San Diego.
- Completed
- Registry status
- Phase 4
- Development phase
- 48
- Enrollment target
NCT02367599 is a Phase 4 study that has completed, run by University of California, San Diego. The registered enrollment target is 48 participants.
The verdict
NCT02367599, a Phase 4 study, has completed, sponsored by University of California, San Diego.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 48 participants
- Enrollment target
Study Summary
CCTG 595 is an open-label clinical trial of the effect of a text messaging intervention vs. standard of care on adherence to Truvada as PrEP in MSM at increased risk for HIV infection (ClinicalTrials.gov Identifier: NCT01761643). Eligible subjects for this matched case control substudy will receive vitamin D 4000 IU/day for 24 weeks, from week 24 through week 48. In CCTG 595, plasma from participants are being collected and stored at entry and every 12 weeks. These plasma samples will be used to measure P1NP, CTX, PTH, and vitamin D levels in both cases and controls at entry, week 24, and week 48.
Interventions
- DRUG Vitamin D Supplement
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 48 participants |
| Start Date | 2014-12-15 |
| Est. Completion | 2018-07-11 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02367599
The ClinicalTrials.gov registry entry for NCT02367599 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 48 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, San Diego, which has 775 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Vitamin D Supplement is the first listed.
NCT02367599 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02367599 about?
NCT02367599 is a clinical study titled "Effect of Vitamin D Supplementation on Bone Turnover Markers During PrEP in MSM". CCTG 595 is an open-label clinical trial of the effect of a text messaging intervention vs. standard of care on adherence to Truvada as PrEP in MSM at increased risk for HIV infection (ClinicalTrials.gov Identifier: NCT01761643). Eligible subjects for this matched case control substudy will receive ...
What is the current status of trial NCT02367599?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 48 participants. The study started on 2014-12-15. Estimated completion is 2018-07-11.
What interventions are being tested in trial NCT02367599?
The interventions under investigation include: Vitamin D Supplement (DRUG).
Who is sponsoring clinical trial NCT02367599?
This trial is sponsored by University of California, San Diego, which has 775 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.